Novartis Investigative Site

Parma 43100

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Non-Small Cell Lung Cancer, Non-infectious Uveitis

Studies at this site

• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis — Stopped early
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed